Aytu Biopharma Inc (AYTU)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0100 (-0.80%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2400 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,844 | -17,051 | -108,779 | -58,289 | -13,621 |
| Depreciation Amortization | 8,869 | 9,374 | 85,478 | 21,982 | 6,246 |
| Accounts receivable | 5,320 | -7,153 | 6,533 | 1,544 | -3,561 |
| Accounts payable and accrued liabilities | -2,879 | 2,384 | N/A | N/A | N/A |
| Other Working Capital | -4,660 | -5,799 | -10,863 | 1,681 | -13,875 |
| Other Operating Activity | 7,806 | 13,116 | -1,192 | 7,118 | -3,563 |
| Operating Cash Flow | $-1,388 | $-5,129 | $-28,823 | $-25,964 | $-28,374 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2,341 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 202 | -5,459 |
| Other Investing Activity | -329 | -117 | -3,248 | -643 | -197 |
| Investing Cash Flow | $-329 | $-117 | $-3,248 | $-2,782 | $-5,656 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 832 | -2,250 | N/A | 51,206 | N/A |
| Debt Issued | 13,000 | N/A | 15,000 | 0 | 3,188 |
| Debt Repayment | -18,288 | -4,362 | -20,510 | -7,056 | -19,437 |
| Common Stock Issued | 3,467 | 15,575 | 11,694 | 40,148 | 92,722 |
| Other Financing Activity | -273 | -92 | -4,654 | -53,984 | -5,404 |
| Financing Cash Flow | $-1,262 | $8,871 | $1,530 | $30,314 | $71,069 |
| Beginning Cash Position | 22,985 | 19,360 | 49,901 | 48,333 | 11,294 |
| End Cash Position | 20,006 | 22,985 | 19,360 | 49,901 | 48,333 |
| Net Cash Flow | $-2,979 | $3,625 | $-30,541 | $1,568 | $37,039 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,388 | -5,129 | -28,823 | -25,964 | -28,374 |
| Capital Expenditure | N/A | N/A | N/A | -2,341 | 0 |
| Free Cash Flow | -1,388 | -5,129 | -28,823 | -28,305 | -28,374 |